Coherus Oncology, Inc. Common Stock
CHRS
CHRS
75 hedge funds and large institutions have $385M invested in Coherus Oncology, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 17 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
-2
Holders Change %
-2.6%
% of All Funds
2%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
17
Increased
28
Reduced
17
Closed
18
Calls
$87K
Puts
–
Net Calls
+$87K
Net Calls Change
+$237K
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$125M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$45.1M |
| 3 |
3
Axa
Paris,
France
|
$9.53M |
| 4 |
4
Wellington Management Group
Boston,
Massachusetts
|
$8.1M |
| 5 |
BM
5
Bridger Management
New York
|
$7.24M |
